Oral vaccines and novel tech: CEPI announces grants for 'variant-proof' COVID-19 vaccine development
CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the first funding awards under a $200m program to advance development of vaccines against SARS-CoV-2 variants and other betacoronaviruses.
View the full story here: https://www.biopharma-reporter.com/Article/2021/11/05/Oral-vaccines-novel-tech-CEPI-grants-for-variant-proof-COVID-19-vaccines